<DOC>
	<DOCNO>NCT02792283</DOCNO>
	<brief_summary>The objective evaluate function platelet patient undergoing hemodialysis . The investigator use assay call PFA-100 , vitro whole blood assay three pathway platelet activation describe platelet response profile . The hypothesis patient undergoing hemodialysis present platelet dysfunction , may reverse hemodialysis . The effect heparin , use hemodialysis session anticoagulate hemodialyzer , platelet function assess .</brief_summary>
	<brief_title>Platelet Function Hemodialysis Patient</brief_title>
	<detailed_description>The aim study evaluate platelet function hemodialysis . One hundred patient end-stage renal disease undergoing hemodialysis ( 2 3 session per week , 3 4 hour per session ) include . Patients meet inclusion criterion include oral write information signature write consent . The study consist record clinical biological evaluation platelet function PFA-100 assay . This whole blood platelet function assay , 3 pathway platelet activation ( collagen-epinephrine , collagen-ADP specific P2Y cartridge - Innovance® ) . Whole blood collect arterial line arteriovenous vascular access ( fistula graft ) hemodialysis session . PFA-100 assayed within 2 hour blood collection platelet response profile interpret accord manufacturer instruction . Clinical information , especially hemorragic thrombotic history , collect day inclusion 6 month inclusion .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Inclusion criterion : patient endstage chronic kidney disease undergoing hemodialysis age ≥ 18 year old hemodialysis peripheral vascular access ( arteriovenous fistula graft ) hematocrit 0.35 0.50 platelet count 150 500 G/L write consent oral write information Exclusion criterion : pregnancy , breast feeding legal guardianchip hemodialysis catheter inability sign consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>